α-D-Glucosyl hesperidin

α-D-Glucosyl hesperidin 是一种口服有效的 Hesperidin (MS-P90195) 结构修饰衍生物,具有抗凋亡 (apoptosis) 和抗氧化活性,可上调 Bcl-2 基因表达并下调 Bax 和 caspase-3 基因表达,提高总抗氧化能力、SOD 和过氧化氢酶水平,降低丙二醛和谷胱甘肽水平,改善精子活力、存活率及质膜功能,恢复生殖器官重量与生精小管结构,提高生育指数,并在睾丸缺血再灌注损伤雄性大鼠中与 Proanthocyanidins (MS-E17436) 具有协同保护作用,可用于睾丸缺血再灌注损伤的研究。
产品编号: MS-N31630 CAS No.: 161713-86-6 分子式: C34H44O20 分子量: 772.70
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

α-D-Glucosyl hesperidin 是一种口服有效的 Hesperidin (MS-P90195) 结构修饰衍生物,具有抗凋亡 (apoptosis) 和抗氧化活性,可上调 Bcl-2 基因表达并下调 Bax 和 caspase-3 基因表达,提高总抗氧化能力、SOD 和过氧化氢酶水平,降低丙二醛和谷胱甘肽水平,改善精子活力、存活率及质膜功能,恢复生殖器官重量与生精小管结构,提高生育指数,并在睾丸缺血再灌注损伤雄性大鼠中与 Proanthocyanidins (MS-E17436) 具有协同保护作用,可用于睾丸缺血再灌注损伤的研究。

生物实验数据

生物活性 α-D-Glucosyl hesperidin is an orally effective structurally modified derivative of Hesperidin (MS-P90195) that possesses anti-apoptotic and antioxidant activities, upregulates Bcl-2 gene expression while downregulating Bax and caspase-3 gene expression, increases total antioxidant capacity, SOD and catalase levels, decreases malondialdehyde and glutathione levels, improves sperm motility, viability and plasma membrane function, restores reproductive organ weight and seminiferous tubule structure, enhances the fertility index, and exerts synergistic protective effects with Proanthocyanidins (MS-E17436) in male rats with testicular ischemia-reperfusion injury, and can be used for the study of testicular ischemia-reperfusion injury.
体内研究
(In Vivo)

α-D-Glucosyl hesperidin (25-50 mg/kg;口服;扭转复位前 30 分钟单次给药) 保护 Wistar 大鼠免受睾丸缺血再灌注损伤。

Animal Model: Wistar (male, 12-14 weeks old, 260-300 g, testicular ischemia-reperfusion injury induced by 2 hours of 720° testicular torsion followed by detorsion)
Dosage: 25 mg/kg; 50 mg/kg
Administration: p.o.; single dose 30 minutes before detorsion
Result: Increased sperm concentration (32.05 ×10⁶/mL), total motility (54.68%), progressive motility (20.53%), kinematic parameters (VAP 23.82 μM/s, VCL 57.78 μM/s, VSL 7.52 μM/s, ALH 4.84 μM/s, BCF 6.95 Hz), membrane functionality (55.48%), and viability (57.29%), while reducing DNA damage (36.15%) and abnormal morphology (34.53%) at 25 mg/kg.
Increased sperm concentration (45.47 ×10⁶/mL), total motility (68.13%), progressive motility (33.45%), kinematic parameters (VAP 28.02 μM/s, VCL 74.89 μM/s, VSL 10.34 μM/s, ALH 5.56 μM/s, BCF 9.06 Hz), membrane functionality (68.47%), and viability (71.87%), while reducing DNA damage (16.93%) and abnormal morphology (23.52%) at 50 mg/kg.
Increased testis weight, epididymis weight, testis/body weight ratio, Johnsen score, seminiferous tubule diameter, Sertoli cell index, repopulation index, mitotic index, Leydig cell nuclear diameter, tubular differentiation index, and spermiogenesis index at 25 mg/kg, while reducing Cosentino score (2.95).
Increased the same reproductive indices more markedly at 50 mg/kg, including testis weight (0.891 g), epididymis weight (0.593 g), testis/body weight ratio (0.34%), Johnsen score (6.64), and seminiferous tubule diameter (195.79 μM), while further reducing Cosentino score (2.13).
Increased total antioxidant capacity (5 mM/mg protein), catalase (0.08 U/mg protein), and superoxide dismutase (18 nmol/mg protein), while reducing glutathione (15 nM/mg protein) and malondialdehyde (500 μM/g protein) at 25 mg/kg.
Increased antioxidant defenses further at 50 mg/kg (TAC 9 mM/mg protein, CAT 0.09 U/mg protein, SOD 22 nM/mg protein), while reducing glutathione (13 nM/mg protein) and malondialdehyde (400 μM/g protein).
Increased Bcl-2 mRNA expression while reducing Bax and caspase-3 expression at both doses, with stronger effects at 50 mg/kg (Bcl-2 0.7-fold; Bax 1.0; caspase-3 1.2).
Increased reproductive performance, including corpora lutea, implants, viable fetuses, pregnancy index, male fertility index, and fertility potential, while reducing preimplantation loss at 25 mg/kg (45.89%) and 50 mg/kg (20.47%), with greater improvement at 50 mg/kg.

化学信息

分子量 772.70
分子式 C34H44O20
CAS No. 161713-86-6

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础